FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016927330> ?p ?o ?g. }

• W3016927330 abstract "Patients undergoing treatment for acute lymphoblastic leukemia (ALL) are at risk for thrombosis, in part due to the use of L-asparaginase (L-ASP). Antithrombin (AT) replacement has been suggested to prevent VTE and thus might increase exposure to ASP. We report herein the results of the prophylactic replacement strategy in the pediatric-inspired prospective GRAALL-2005 study. Between 2006 and 2014, 784 adult patients with newly diagnosed Philadelphia-negative ALL were included. The incidence rate of VTE was 16% with 69% of them occurring during induction therapy. Most patients received AT supplementation (87%). After excluding patients who did not receive L-ASP or developed thrombosis before L-ASP, AT supplementation did not have a significant impact on VTE (8% versus 14%, OR: 0.6, p=0.1). Fibrinogen concentrates administration was associated with an increased risk of VTE (17% versus 9%, OR 2.2, p=0.02) whereas transfusion of fresh-frozen plasma had no effect. Heparin prophylaxis was associated with an increased risk of VTE (13% versus 7%, OR 1.9, p=0.04). Prophylactic measures were not associated with an increased risk of grade 3-4 bleeding complications. The rate of VTE recurrence after L-ASP reintroduction was 3% (1/34). In ALL patients receiving L-ASP therapy, the use of fibrinogen concentrates may increase the risk of thrombosis and should be restricted to rare patients with hypofibrinogenemia-induced hemorrhage. Patients developed VTE despite extensive AT supplementation which advocates for additional prophylactic measures. While this large descriptive study was not powered to demonstrate the efficacy of these prophylactic measures, it provides important insight to guide future trial design. NCT00327678." @default.
• W3016927330 created "2020-04-24" @default.
• W3016927330 creator A5000436961 @default.
• W3016927330 creator A5004066423 @default.
• W3016927330 creator A5007895303 @default.
• W3016927330 creator A5007908757 @default.
• W3016927330 creator A5009193536 @default.
• W3016927330 creator A5010632074 @default.
• W3016927330 creator A5014517118 @default.
• W3016927330 creator A5021739338 @default.
• W3016927330 creator A5023091403 @default.
• W3016927330 creator A5032490484 @default.
• W3016927330 creator A5036207495 @default.
• W3016927330 creator A5037324033 @default.
• W3016927330 creator A5046713117 @default.
• W3016927330 creator A5064941466 @default.
• W3016927330 creator A5075950291 @default.
• W3016927330 creator A5076973611 @default.
• W3016927330 creator A5085953785 @default.
• W3016927330 creator A5086300417 @default.
• W3016927330 creator A5090388430 @default.
• W3016927330 date "2020-04-22" @default.
• W3016927330 modified "2023-10-17" @default.
• W3016927330 title "Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study" @default.
• W3016927330 cites W1504555330 @default.
• W3016927330 cites W1756835868 @default.
• W3016927330 cites W1855466123 @default.
• W3016927330 cites W1887863677 @default.
• W3016927330 cites W1912493834 @default.
• W3016927330 cites W1963808445 @default.
• W3016927330 cites W1969176274 @default.
• W3016927330 cites W1982505387 @default.
• W3016927330 cites W1988877817 @default.
• W3016927330 cites W1990750943 @default.
• W3016927330 cites W1993211677 @default.
• W3016927330 cites W1999820147 @default.
• W3016927330 cites W2010623441 @default.
• W3016927330 cites W2027460583 @default.
• W3016927330 cites W2028757835 @default.
• W3016927330 cites W2034485178 @default.
• W3016927330 cites W2035925896 @default.
• W3016927330 cites W2038613090 @default.
• W3016927330 cites W2048417403 @default.
• W3016927330 cites W2052739233 @default.
• W3016927330 cites W2053817144 @default.
• W3016927330 cites W2055736858 @default.
• W3016927330 cites W2056263738 @default.
• W3016927330 cites W2058534416 @default.
• W3016927330 cites W2061255438 @default.
• W3016927330 cites W2080525555 @default.
• W3016927330 cites W2089471154 @default.
• W3016927330 cites W2097682287 @default.
• W3016927330 cites W2121951546 @default.
• W3016927330 cites W2122540770 @default.
• W3016927330 cites W2131184407 @default.
• W3016927330 cites W2144921015 @default.
• W3016927330 cites W2146762986 @default.
• W3016927330 cites W2150036781 @default.
• W3016927330 cites W2166140055 @default.
• W3016927330 cites W2169732420 @default.
• W3016927330 cites W2174610917 @default.
• W3016927330 cites W2189457108 @default.
• W3016927330 cites W2197510804 @default.
• W3016927330 cites W2210387293 @default.
• W3016927330 cites W2305866219 @default.
• W3016927330 cites W2336096370 @default.
• W3016927330 cites W2337715678 @default.
• W3016927330 cites W2485785171 @default.
• W3016927330 cites W2509642739 @default.
• W3016927330 cites W2520695016 @default.
• W3016927330 cites W2563361324 @default.
• W3016927330 cites W2612368046 @default.
• W3016927330 cites W2770856392 @default.
• W3016927330 cites W2789709299 @default.
• W3016927330 cites W2802993328 @default.
• W3016927330 cites W2803413274 @default.
• W3016927330 cites W2806642795 @default.
• W3016927330 cites W2892578575 @default.
• W3016927330 cites W2897460504 @default.
• W3016927330 cites W2908746540 @default.
• W3016927330 cites W2937276189 @default.
• W3016927330 cites W2939150686 @default.
• W3016927330 cites W2945001473 @default.
• W3016927330 cites W2983476584 @default.
• W3016927330 cites W98363274 @default.
• W3016927330 doi "https://doi.org/10.1182/blood.2020004919" @default.
• W3016927330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32321172" @default.
• W3016927330 hasPublicationYear "2020" @default.
• W3016927330 type Work @default.
• W3016927330 sameAs 3016927330 @default.
• W3016927330 citedByCount "15" @default.
• W3016927330 countsByYear W30169273302020 @default.
• W3016927330 countsByYear W30169273302021 @default.
• W3016927330 countsByYear W30169273302022 @default.
• W3016927330 countsByYear W30169273302023 @default.
• W3016927330 crossrefType "journal-article" @default.
• W3016927330 hasAuthorship W3016927330A5000436961 @default.
• W3016927330 hasAuthorship W3016927330A5004066423 @default.
• W3016927330 hasAuthorship W3016927330A5007895303 @default.
• W3016927330 hasAuthorship W3016927330A5007908757 @default.

• next